DOCSLIB.ORG

Microglia Emerge from Erythromyeloid Precursors Via Pu.1- and Irf8-Dependent Pathways

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Microglia Emerge from Erythromyeloid Precursors Via Pu.1- and Irf8-Dependent Pathways ART ic LE S Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways Katrin Kierdorf1,2, Daniel Erny1, Tobias Goldmann1, Victor Sander1, Christian Schulz3,4, Elisa Gomez Perdiguero3,4, Peter Wieghofer1,2, Annette Heinrich5, Pia Riemke6, Christoph Hölscher7,8, Dominik N Müller9, Bruno Luckow10, Thomas Brocker11, Katharina Debowski12, Günter Fritz1, Ghislain Opdenakker13, Andreas Diefenbach14, Knut Biber5,15, Mathias Heikenwalder16, Frederic Geissmann3,4, Frank Rosenbauer6 & Marco Prinz1,17 Microglia are crucial for immune responses in the brain. Although their origin from the yolk sac has been recognized for some time, their precise precursors and the transcription program that is used are not known. We found that mouse microglia were derived from primitive c-kit+ erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception. + lo − + − + These precursors developed into CD45 c-kit CX3CR1 immature (A1) cells and matured into CD45 c-kit CX3CR1 (A2) cells, as evidenced by the downregulation of CD31 and concomitant upregulation of F4/80 and macrophage colony stimulating factor receptor (MCSF-R). Proliferating A2 cells became microglia and invaded the developing brain using specific matrix metalloproteinases. Notably, microgliogenesis was not only dependent on the transcription factor Pu.1 (also known as Sfpi), but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required. Our data provide cellular and molecular insights into the origin and development of microglia. Microglia are the tissue macrophages of the brain and scavenge dying have the ability to give rise to microglia and macrophages in vitro cells, pathogens and molecules using pattern recognition receptors and in vivo under defined conditions. During their journey into the and subsequent phagocytosis and endocytosis1–3. Unlike macroglia developing CNS, these cells acquired macrophage-specific markers (astrocytes and oligodendrocytes) and neurons, which are derived and finally settled in the target tissue, where they differentiated into from the neuroectoderm, microglia progenitors arise from the periph- definitive microglia with fine processes. Of note, this extremely com- eral mesodermal tissue4,5. Their origin from the yolk sac, which was plex developmental process required specific molecules that could © 2013 Nature America, Inc. All rights reserved. America, Inc. © 2013 Nature proposed in 1999 (ref. 6), was confirmed by two recent fate-mapping be identified at defined time points. Our results describe microglia studies7,8. One study used a tamoxifen-inducible Cre recombinase as a distinct tissue-specific macrophage population that is clearly under the control of Runx1, a transcription factor involved in the genetically different from circulating myeloid cells. npg development of all lineages of normal hematopoiesis7. In a more recent study, we found that microglia were derived from MCSF- RESULTS R–expressing yolk sac precursors that were present between 8.5 and c-kit+ erythromyeloid cells are the microglia progenitors 9.5 days post conception (dpc)8. However, these studies focused on To follow the fate of late myeloid cells in the brain during embryogen- GFP/wt already committed CX3CR1-expressing yolk sac myeloid cells and esis, we used Cx3cr1 mice, which have a GFP knock-in on one therefore considered immature macrophages to be microglia precur- allele of the Cx3cr1 gene. CX3CR1 is expressed in mature monocytes sors, thereby missing possible earlier progenitors that lack macro- and in a subset of peripheral mononuclear phagocytes. In the brain, phage markers such as F4/80 and CD11b. only microglia express this marker9,10. We found that uncommitted c-kit+ stem cells that have both eryth- We first addressed the question of the origin of Cx3cr1GFP/wt micro- roid and myeloid potential are the direct yolk sac–derived precur- glia progenitors in the mouse embryo. It has been shown that hemato- sors of microglia during early embryogenesis. These primitive cells poietic cells can be independently generated in two distinct sites. 1Department of Neuropathology, University of Freiburg, Freiburg, Germany. 2Faculty of Biology, University of Freiburg, Freiburg, Germany. 3Centre for Molecular and Cellular Biology of Inflammation, King’s College London, London, UK. 4Peter Gorer Department of Immunobiology, King’s College London, London, UK. 5Department of Psychiatry, University of Freiburg, Freiburg, Germany. 6Institute of Molecular Tumor Biology, University of Muenster, Muenster, Germany. 7Division of Infection Immunology, Research Center Borstel, Borstel, Germany. 8Cluster of Excellence, Inflammation at Interfaces (Borstel-Kiel-Lübeck-Plön), Kiel, Germany. 9Experimental and Clinical Research Center, Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Germany. 10Klinikum der Universität München, Medizinische Klinik und Poliklinik IV, Arbeitsgruppe Klinische Biochemie, München, Germany. 11Institute for Immunology, Ludwig-Maximilians-Universität München, Munich, Germany. 12Cell Research Group, German Primate Center, Göttingen, Germany. 13Department of Microbiology and Immunology, Rega Institute for Medical Research, University of Leuven, Belgium. 14Department of Microbiology, University of Freiburg, Freiburg, Germany. 15Department of Neuroscience, University Medical Center Groningen, Groningen, The Netherlands. 16Institute of Virology, Technische Universität München/Helmholtz-Zentrum Munich, Munich, Germany. 17Center for Biological Signaling Studies, University of Freiburg, Freiburg, Germany. Correspondence should be addressed to M.P. ([email protected]). Received 6 November 2012; accepted 21 December 2012; published online 20 January 2013; corrected online 6 February 2013 (details online); doi:10.1038/nn.3318 NATURE NEUROSCIENCE VOLUME 16 | NUMBER 3 | MARCH 2013 273 ART ic LE S dpc 8.0 dpc 9.0 CX CR1+ a b Cell population 3 Ter119+ day 7 CD45+ day 7 M CD45+ c-kit– nd nd 4.9 A – – A1 A2 CD45 c-kit nd nd CD45 CD45– c-kit+ (EMP) 70–80% 5–10% 1.8 BC c-kit c-kit CX3CR1-GFP 78.2 CD45 Yolk sac macrophages dpc 10.5 A1 A2 FSC-A 5.3 CX3CR1-GFP Ter119 A A1 A2 56.5 3.9 CD45 Cell population CX CR1+ CX CR1+ BC c 3 3 CD45+ day 7 CD45+ day 28 c-kit CX3CR1-GFP c-kit c-kit + – CD45 CX3CR1 (A1) 5–15% >90% Head macrophages dpc 10.5 A1 A2 + + CD45 CX3CR1 (A2) nd nd A A1 A2 10.2 0.0 10.7 99.5 CD45 CD45 CD45 BC c-kit CX CR1-GFP c-kit c-kit 3 CX3CR1-GFP CX3CR1-GFP d Depleted EMP transplanted CD45+ c-kit– transplanted A1 transplanted A2 transplanted Iba-1 Iba-1 DAPI CX3CR1 Iba-1 CX3CR1 CX3CR1 CX3CR1 CX3CR1 CX3CR1 e EMP CD45+ c-kit– macrophages Adult microglia © 2013 Nature America, Inc. All rights reserved. America, Inc. © 2013 Nature EMP CD45+ c-kit– macrophages 15 µm 15 µm 13 µm Adult microglia npg 800 Dendrite length 80 Branching points 150 Dendrite segments 80 Dendrite m) terminal points µ 600 60 60 100 400 40 40 *** *** *** 50 *** Number of Number of 200 20 Number of 20 branching points dendrite segments Dendrite length ( 0 0 0 dendrite terminal points 0 Figure 1 Identification and characterization of the microglia progenitor. (a) Top, fractionation of 8.0-dpc yolk sac cells using CD45 and c-kit markers allowed for distinction of separate subsets of precursor cells by fluorescence-activated cell sorting (FACS, left). We analyzed 9.0-dpc yolk sac from a GFP/GFP wt/wt + male Cx3cr1 and female Cx3cr1 mating (right). Separation of CD45 cells allowed for discrimination of two subsets designated A1 (CX3CR1- − + + − GFP ) and A2 (CX3CR1-GFP ) and a maternal (M) CD45 CX3CR1-GFP population. Middle and bottom, characterization of myeloid precursors in the yolk sac and the head at 10.5 dpc. In the CD45-expressing cells in the brain, GFP+ and GFP− populations were found. The CD45 fraction in the yolk sac can be further subdivided according to different levels of c-kit expression, namely into CD45+ c-kit− and CD45+ c-kit+ in A1 and a single CD45+ c-kit− population in A2. Data are representative of four independent experiments. Percentages are indicated. (b) In vitro differentiation potential of 8.0-dpc yolk sac subsets defined in a. The hematopoietic potential was strictly ascribed to the CD45− c-kit+ subset that comprised myeloid and erythroid precursors, a characteristic feature of EMPs. Data are representative of three independent experiments. nd, not detectable. (c) In vitro differentiation potential of 9.0-dpc yolk sac populations shown in a. Only c-kit+ A1 cells differentiated into the myeloid lineage at the indicated time points. Representative dot plots are depicted. Morphology of the cultured cells is illustrated with Pappenheim staining. Data are representative of two independent experiments. (d) Differentiation of adoptively transferred yolk sac subsets on organotypic hippocampal brain slice cultures depleted of endogenous microglia before cell transfer. At 12 d in culture, transferred yolk sac cells from embryos of a male Cx3cr1GFP/GFP and female Cx3cr1wt/wt cross-breeding were analyzed using the macrophage marker Iba-1 and CX3CR1-GFP. Scale bars represent 200 µm (top panels) and 20 µm (bottom panels and insets). Data are representative of three independent experiments. (e) Three-dimensional reconstruction (top) and Imaris-based automatic quantification of cell morphology (bottom) of transferred cells. Data represent means ± s.e.m. of at least five cells per group. ***P < 0.001. Data are representative of two independent experiments. 274 VOLUME 16 | NUMBER 3 | MARCH 2013 NATURE NEUROSCIENCE ART ic LE S The first site, the yolk sac, generates erythroid cells and macrophages that could act as the direct microglia precursors. To test the potential starting at 7.5–8.0 dpc, that is, before microglia progenitors are first of yolk sac cells to differentiate into microglia cells in situ, we used detected in the neural folds11–13. To determine whether the yolk sac microglia-free organotypic hippocampal slice cultures (OHSCs) as contains progenitor cells with macrophage properties, we analyzed described previously15 (Fig. 1d).
Load more

Recommended publications
  • RBP-J Signaling − Cells Through Notch Novel IRF8-Controlled
    Sca-1+Lin−CD117− Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IRF8-Controlled Regulatory Dendritic Cells through Notch −RBP-J Signaling This information is current as of September 25, 2021. Xingxia Liu, Shaoda Ren, Chaozhuo Ge, Kai Cheng, Martin Zenke, Armand Keating and Robert C. H. Zhao J Immunol 2015; 194:4298-4308; Prepublished online 30 March 2015; doi: 10.4049/jimmunol.1402641 Downloaded from http://www.jimmunol.org/content/194/9/4298 Supplementary http://www.jimmunol.org/content/suppl/2015/03/28/jimmunol.140264 http://www.jimmunol.org/ Material 1.DCSupplemental References This article cites 59 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/194/9/4298.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 25, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Sca-1+Lin2CD1172 Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IRF8-Controlled Regulatory Dendritic Cells through Notch–RBP-J Signaling Xingxia Liu,*,1 Shaoda Ren,*,1 Chaozhuo Ge,* Kai Cheng,* Martin Zenke,† Armand Keating,‡,x and Robert C.
    [Show full text]
  • Roles and Regulation of Transcription Factor Mafa in Islet Β-Cells
    Endocr. J./ S. ARAMATA et al.: INSULIN TRANSCRIPTION AND MafA doi: 10.1507/endocrj.KR-101 REVIEW Roles and Regulation of Transcription Factor MafA in Islet β-cells * SHINSAKU ARAMATA, SONG-IEE HAN AND KOHSUKE KATAOKA Graduate School of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630-0192, Japan ＊Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba Science City, Ibaraki 305-8572, Japan. Released online August 30, 2007 Correspondence to: Kohsuke KATAOKA, Graduate School of Biological Science, Nara Institute of Science and Technology, 8916-5 Takayama-cho, Ikoma, Nara 630-0192, Japan Abstract. Insulin is a critical hormone in the regulation of blood glucose levels. It is produced exclusively by pancreatic islet β-cells. β-cell-enriched transcription factors, such as Pdx1 and Beta2, have dual roles in the activation of the insulin gene promoter establishing β-cell-specific insulin expression, and in the regulation of β-cell differentiation. It was shown that MafA, a β-cell-specific member of the Maf family of transcription factors, binds to the conserved C1/RIPE3b element of the insulin promoter. The Maf family proteins regulate tissue-specific gene expression and cell differentiation in a wide variety of tissues. MafA acts synergistically with Pdx1 and Beta2 to activate the insulin gene promoter, and mice with a targeted deletion of mafA develop age-dependent diabetes. MafA also regulates genes involved in β-cell function such as Glucose transporter 2, Glucagons-like peptide 1 receptor, and Prohormone convertase 1/3. The abundance of MafA in β-cells is regulated at both the transcriptional and post-translational levels by glucose and oxidative stress.
    [Show full text]
  • The Transcription Factors C-Myb and GATA-2 Act Independently in The
    Proc. Natl. Acad. Sci. USA Vol. 93, pp. 5313-5318, May 1996 Medical Sciences The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis PAOLA MELOTrl AND BRUNO CALABRETTA Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, 233 South 10th Street, Philadelphia, PA 19107 Communicated by Sidney Weinhouse, Thomas Jefferson University, Philadelphia, PA, January 23, 1996 (received for review, October 20, 1995) ABSTRACT The transcription factors c-myb and GATA-2 erythromyeloid differentiation (7). This process appears to are both required for blood cell development in vivo and in rest in the ability of c-myb to activate the expression of vitro. However, very little is known on their mechanism(s) of hematopoiesis-specific targets such as c-kit,flt-3, GATA-1, and action and whether they impact on complementary or over- CD34, but not GATA-2 (7). The induction of c-kit and flt-3 lapping pathways of hematopoietic proliferation and differ- expression and the dependence of c-myb-transfected ES cells entiation. We report here that embryonic stem (ES) cells on the expression of these cytokine receptors for their prolif- transfected with c-myb or GATA-2 cDNAs, individually or in eration (7) strongly suggest that the up-regulation of growth combination, underwent hematopoietic commitment and dif- factor receptor levels is of fundamental importance for the ferentiation in the absence of added hematopoietic growth expansion of progenitor cells. In turn, such a process is factors but that stimulation with c-kit and flt-3 ligands en- probably a requirement for completion of the differentiation hanced colony formation only in the c-myb transfectants.
    [Show full text]
  • Differential Expression of Vitamin D Binding Protein in Thyroid Cancer Health Disparities
    www.oncotarget.com Oncotarget, 2021, Vol. 12, (No. 7), pp: 596-607 Research Paper Differential expression of Vitamin D binding protein in thyroid cancer health disparities Brittany Mull1, Ryan Davis2,3, Iqbal Munir4, Mia C. Perez5, Alfred A. Simental6 and Salma Khan2,3,6,7 1Harbor UCLA Medical Center, Torrance, CA 90502, USA 2Division of Biochemistry, Loma Linda, CA 92350, USA 3Center for Health Disparities & Molecular Medicine, Loma Linda, CA 92350, USA 4Riverside University Health System, Moreno Valley, CA 92555, USA 5Department of Pathology & Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA 6Department of Otolaryngology, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA 7Department of Internal Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA Correspondence to: Salma Khan, email: [email protected] Keywords: DBP; thyroid cancer; health disparities Received: November 16, 2020 Accepted: March 05, 2021 Published: March 30, 2021 Copyright: © 2021 Mull et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT Thyroid cancer incidence, recurrence, and death rates are higher among Filipino Americans than European Americans. We propose that vitamin D binding protein (DBP) with multifunctionality with ethnic variability plays a key role within different ethnicities. In this study, we determined the correlation between differential DBP expression in tumor tissues and cancer staging in Filipino Americans versus European Americans. We assayed DBP expression by immunohistochemistry and analyzed the data with confocal microscopy on 200 thyroid cancer archival tissue samples obtained from both ethnicities.
    [Show full text]
  • Prox1regulates the Subtype-Specific Development of Caudal Ganglionic
    The Journal of Neuroscience, September 16, 2015 • 35(37):12869–12889 • 12869 Development/Plasticity/Repair Prox1 Regulates the Subtype-Specific Development of Caudal Ganglionic Eminence-Derived GABAergic Cortical Interneurons X Goichi Miyoshi,1 Allison Young,1 Timothy Petros,1 Theofanis Karayannis,1 Melissa McKenzie Chang,1 Alfonso Lavado,2 Tomohiko Iwano,3 Miho Nakajima,4 Hiroki Taniguchi,5 Z. Josh Huang,5 XNathaniel Heintz,4 Guillermo Oliver,2 Fumio Matsuzaki,3 Robert P. Machold,1 and Gord Fishell1 1Department of Neuroscience and Physiology, NYU Neuroscience Institute, Smilow Research Center, New York University School of Medicine, New York, New York 10016, 2Department of Genetics & Tumor Cell Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, 3Laboratory for Cell Asymmetry, RIKEN Center for Developmental Biology, Kobe 650-0047, Japan, 4Laboratory of Molecular Biology, Howard Hughes Medical Institute, GENSAT Project, The Rockefeller University, New York, New York 10065, and 5Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 Neurogliaform (RELNϩ) and bipolar (VIPϩ) GABAergic interneurons of the mammalian cerebral cortex provide critical inhibition locally within the superficial layers. While these subtypes are known to originate from the embryonic caudal ganglionic eminence (CGE), the specific genetic programs that direct their positioning, maturation, and integration into the cortical network have not been eluci- dated. Here, we report that in mice expression of the transcription factor Prox1 is selectively maintained in postmitotic CGE-derived cortical interneuron precursors and that loss of Prox1 impairs the integration of these cells into superficial layers. Moreover, Prox1 differentially regulates the postnatal maturation of each specific subtype originating from the CGE (RELN, Calb2/VIP, and VIP).
    [Show full text]
  • Cells Transformed by a V-Myb-Estrogen Receptor Fusion Differentiate Into Multinucleated Giant Cells
    JOURNAL OF VIROLOGY, May 1997, p. 3760–3766 Vol. 71, No. 5 0022-538X/97/$04.0010 Copyright q 1997, American Society for Microbiology Cells Transformed by a v-Myb-Estrogen Receptor Fusion Differentiate into Multinucleated Giant Cells UTE ENGELKE, DUEN-MEI WANG, AND JOSEPH S. LIPSICK* Department of Pathology, Stanford University School of Medicine, Stanford, California 94305-5324 Received 22 October 1996/Accepted 29 January 1997 In order to make conditional alleles of the v-myb oncogene, we constructed and tested avian retroviruses which produce a number of different fusion proteins between v-Myb and the human estrogen receptor (ER). We found that the portion of the ER used in making these fusions profoundly affected their transcriptional activation. However, all the fusions tested were only weakly transforming in embryonic yolk sac assays and there was no direct correlation between the level of transcriptional activation and strength of oncogenic transformation. Nevertheless, transformation by a v-Myb-ER fusion was estrogen dependent, and upon with- drawal of the hormone, monocytic-lineage cells differentiated into multinucleated giant cells. Surprisingly, the withdrawal of estrogen caused a dramatic increase in the stability of the fusion protein, although it remained unable to promote cell growth or block differentiation. Conditional alleles of retroviral oncogenes have provided genes, have been isolated and analyzed in considerable detail powerful tools with which to dissect the mechanism of onco- (3, 4). A differential cDNA screen has identified a target gene, genic transformation and the biology of transformed cells (17, mim-1, which is directly activated by the Gag-Myb-Ets protein 29).
    [Show full text]
  • A Flexible Microfluidic System for Single-Cell Transcriptome Profiling
    www.nature.com/scientificreports OPEN A fexible microfuidic system for single‑cell transcriptome profling elucidates phased transcriptional regulators of cell cycle Karen Davey1,7, Daniel Wong2,7, Filip Konopacki2, Eugene Kwa1, Tony Ly3, Heike Fiegler2 & Christopher R. Sibley 1,4,5,6* Single cell transcriptome profling has emerged as a breakthrough technology for the high‑resolution understanding of complex cellular systems. Here we report a fexible, cost‑efective and user‑ friendly droplet‑based microfuidics system, called the Nadia Instrument, that can allow 3′ mRNA capture of ~ 50,000 single cells or individual nuclei in a single run. The precise pressure‑based system demonstrates highly reproducible droplet size, low doublet rates and high mRNA capture efciencies that compare favorably in the feld. Moreover, when combined with the Nadia Innovate, the system can be transformed into an adaptable setup that enables use of diferent bufers and barcoded bead confgurations to facilitate diverse applications. Finally, by 3′ mRNA profling asynchronous human and mouse cells at diferent phases of the cell cycle, we demonstrate the system’s ability to readily distinguish distinct cell populations and infer underlying transcriptional regulatory networks. Notably this provided supportive evidence for multiple transcription factors that had little or no known link to the cell cycle (e.g. DRAP1, ZKSCAN1 and CEBPZ). In summary, the Nadia platform represents a promising and fexible technology for future transcriptomic studies, and other related applications, at cell resolution. Single cell transcriptome profling has recently emerged as a breakthrough technology for understanding how cellular heterogeneity contributes to complex biological systems. Indeed, cultured cells, microorganisms, biopsies, blood and other tissues can be rapidly profled for quantifcation of gene expression at cell resolution.
    [Show full text]
  • A Dual Cis-Regulatory Code Links IRF8 to Constitutive and Inducible Gene Expression in Macrophages
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press A dual cis-regulatory code links IRF8 to constitutive and inducible gene expression in macrophages Alessandra Mancino,1,3 Alberto Termanini,1,3 Iros Barozzi,1 Serena Ghisletti,1 Renato Ostuni,1 Elena Prosperini,1 Keiko Ozato,2 and Gioacchino Natoli1 1Department of Experimental Oncology, European Institute of Oncology (IEO), 20139 Milan, Italy; 2Laboratory of Molecular Growth Regulation, Genomics of Differentiation Program, National Institute of Child Health and Human Development (NICHD), National Institutes of Health, Bethesda, Maryland 20892, USA The transcription factor (TF) interferon regulatory factor 8 (IRF8) controls both developmental and inflammatory stimulus-inducible genes in macrophages, but the mechanisms underlying these two different functions are largely unknown. One possibility is that these different roles are linked to the ability of IRF8 to bind alternative DNA sequences. We found that IRF8 is recruited to distinct sets of DNA consensus sequences before and after lipopolysaccharide (LPS) stimulation. In resting cells, IRF8 was mainly bound to composite sites together with the master regulator of myeloid development PU.1. Basal IRF8–PU.1 binding maintained the expression of a broad panel of genes essential for macrophage functions (such as microbial recognition and response to purines) and contributed to basal expression of many LPS-inducible genes. After LPS stimulation, increased expression of IRF8, other IRFs, and AP-1 family TFs enabled IRF8 binding to thousands of additional regions containing low-affinity multimerized IRF sites and composite IRF–AP-1 sites, which were not premarked by PU.1 and did not contribute to the basal IRF8 cistrome.
    [Show full text]
  • Temporal Mapping of CEBPA and CEBPB Binding
    Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Temporal mapping of CEBPA and CEBPB binding during liver regeneration reveals dynamic occupancy and specific regulatory codes for homeostatic and cell cycle gene batteries Janus Schou Jakobsen1,2,3,*, Johannes Waage1,2,3,4, Nicolas Rapin1,2,3,4, Hanne Cathrine Bisgaard5, Fin Stolze Larsen6, Bo Torben Porse1,2,3,* 1 The Finsen Laboratory, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, DK2200 Copenhagen, Denmark; 2 Biotech Research and Innovation Centre (BRIC), University of Copenhagen, DK-2200 Copenhagen, Denmark; 3 The Danish Stem Cell Centre (DanStem) Faculty of Health Sciences, University of Copenhagen, DK2200 Copenhagen Denmark; 4 The Bioinformatics Centre, University of Copenhagen, DK2200, Copenhagen, Denmark; 5 Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, DK- 2100 Copenhagen, Denmark; 6 Department of Hepatology, Rigshospitalet, DK2200 Copenhagen, Denmark. JW: [email protected]; NR: [email protected]; HCB: [email protected]; FSL: [email protected] * Corresponding authors: BTP: [email protected]; JSJ: [email protected], The Finsen Laboratory, Ole Maaløesvej 5, Copenhagen Biocenter, University of Copenhagen, DK2200 Copenhagen, Denmark. Telephone: +45 3545 6023 Running title: Regulation of liver regeneration Keywords: Temporal ChIP-seq, dynamic binding, liver regeneration, C/EBPalpha, C/EBPbeta, transcriptional networks 1 Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Dynamic shifts in transcription factor binding are central to the regulation of biological processes by allowing rapid changes in gene transcription.
    [Show full text]
  • Transcription Regulation of MYB: a Potential and Novel Therapeutic Target in Cancer
    Review Article Page 1 of 11 Transcription regulation of MYB: a potential and novel therapeutic target in cancer Partha Mitra1,2 1Pre-clinical Division, Vaxxas Pty. Ltd. Translational Research Institute, Woolloongabba QLD 4102, Australia; 2Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Woolloongabba QLD 4102, Australia Correspondence to: Partha Mitra. Pre-clinical Division, Vaxxas Pty. Ltd. Translational Research Institute, 37 Kent St., Woolloongabba QLD 4102, Australia; Queensland University of Technology, Translational Research Institute, 37 Kent St., Woolloongabba QLD 4102, Australia. Email: [email protected]; [email protected]. Abstract: Basal transcription factors have never been considered as a priority target in the field of drug discovery. However, their unparalleled roles in decoding the genetic information in response to the appropriate signal and their association with the disease progression are very well-established phenomena. Instead of considering transcription factors as such a target, in this review, we discuss about the potential of the regulatory mechanisms that control their gene expression. Based on our recent understanding about the critical roles of c-MYB at the cellular and molecular level in several types of cancers, we discuss here how MLL-fusion protein centred SEC in leukaemia, ligand-estrogen receptor (ER) complex in breast cancer (BC) and NF-κB and associated factors in colorectal cancer regulate the transcription of this gene. We further discuss plausible strategies, specific to each cancer type, to target those bona fide activators/co-activators, which control the regulation of this gene and therefore to shed fresh light in targeting the transcriptional regulation as a novel approach to the future drug discovery in cancer.
    [Show full text]
  • Transcriptional Control of Microglia Phenotypes in Health and Disease
    REVIEW SERIES: GLIA AND NEURODEGENERATION The Journal of Clinical Investigation Series Editors: Marco Colonna and David Holtzmann Transcriptional control of microglia phenotypes in health and disease Inge R. Holtman,1,2 Dylan Skola,1 and Christopher K. Glass1,3 1Department of Cellular and Molecular Medicine, UCSD, San Diego, California, USA. 2Department of Medical Physiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. 3Department of Medicine, UCSD, San Diego, California, USA. Microglia are the main resident macrophage population of the CNS and perform numerous functions required for CNS development, homeostasis, immunity, and repair. Many lines of evidence also indicate that dysregulation of microglia contributes to the pathogenesis of neurodegenerative and behavioral diseases. These observations provide a compelling argument to more clearly define the mechanisms that control microglia identity and function in health and disease. In this Review, we present a conceptual framework for how different classes of transcription factors interact to select and activate regulatory elements that control microglia development and their responses to internal and external signals. We then describe functions of specific transcription factors in normal and pathological contexts and conclude with a consideration of open questions to be addressed in the future. Introduction regulatory control necessary to generate cell type–specific programs Microglia are tissue-resident macrophages that perform CNS- of gene expression. This additional information is provided by distal specific functions (1). They derive from a unique lineage of eryth- regulatory elements called enhancers (12). Enhancers represent the romyeloid precursors (EMPs) in the yolk sac and fetal liver (2). most numerous binding sites for LDTFs and signal-dependent tran- EMPs infiltrate the brain during early development, differentiate scription factors (SDTFs), and are major sites for the integration of into microglia, and maintain their population by self-renewal (3).
    [Show full text]
  • Genequery™ Human Stem Cell Transcription Factors Qpcr Array
    GeneQuery™ Human Stem Cell Transcription Factors qPCR Array Kit (GQH-SCT) Catalog #GK125 Product Description ScienCell's GeneQuery™ Human Stem Cell Transcription Factors qPCR Array Kit (GQH-SCT) surveys a panel of 88 transcription factors related to stem cell maintenance and differentiation. Transcription factors are proteins that can regulate target gene transcription level by binding to specific regions of the genome known as enhancers or silencers. Brief examples of how genes may be grouped according to their functions are shown below: • Pluripotency transcription factors: NANOG, POU5F1, SOX2 • Embryonic development: EOMES, FOXC2/D3/O1, HOXA9/A10, KLF2/5, LIN28B, MAX, PITX2, SMAD1, TBX5, ZIC1 • Germ layer formation and differentiation: FOXA2, GATA6, HAND1, ISL1, KLF4, SMAD2, SOX9 • Organ morphogenesis: EZH2, HOXA11/B3/B5/C9, MSX2, MYC, PAX5/8, VDR • Angiogenesis: CDX2, JUN, NR2F2, RUNX1, WT1 • Hematopoiesis and osteogenesis: EGR3, ESR1, GATA1/2/3, GLI2, NFATC1, PAX9, RB1, SOX6, SP1, STAT1 • Neural stem cell maintenance and differentiation: ATF2, CREB1, FOSB, FOXO3, HES1, HOXD10, MCM2/7, MEF2C, NEUROD1/G1, OLIG1/2, PAX3/6, POU4F1, PPARG, SMAD3/4, SNAI1, STAT3 Note : all gene names follow their official symbols by the Human Genome Organization Gene Nomenclature Committee (HGNC). GeneQuery™ qPCR array kits are qPCR ready in a 96-well plate format, with each well containing one primer set that can specifically recognize and efficiently amplify a target gene's cDNA. The carefully designed primers ensure that: (i) the optimal annealing temperature in qPCR analysis is 65°C (with 2 mM Mg 2+ , and no DMSO); (ii) the primer set recognizes all known transcript variants of target gene, unless otherwise indicated; and (iii) only one gene is amplified.
    [Show full text]